Cited by 34Pancreatic function and diabetesDiabetes Treatment and ManagementPeroxisome Proliferator-Activated Receptors

Effects of rosiglitazone and metformin on pancreatic beta cell gene expression

Open access
Richardson, H., Campbell, S. C., Smith, S. A., Macfarlane, W. M.·2006·Diabetologia

Abstract

Aims/hypothesis Rosiglitazone and metformin are two oral antihyperglycaemic drugs used to treat type 2 diabetes. While both drugs have been shown to improve insulin-sensitive glucose uptake, the direct effects of these drugs on pancreatic beta cells is only now beginning to be clarified. The aim of the present study was to determine the direct effects of these agents on beta cell gene expression.Methods We used reporter gene analysis to examine the effects of rosiglitazone and metformin on the activity of the proinsulin and insulin promoter factor 1 (IPF1) gene promoters in the glucose-responsive mouse beta cell line Min6. Western blot and gel retardation analyses were used to examine the effects of both drugs on the regulation of IPF1 protein production, nuclear accumulation and DNA binding activity in both Min6 cells and isolated rat islets of Langerhans.Results Over 24 h, rosiglitazone promoted the nuclear accumulation of IPF1 and forkhead homeobox A2 (FOXA2), independently of glucose concentration, and stimulated a two-fold increase in the activity of the Ipf1 gene promoter (p<0.01). Stimulation of the Ipf1 promoter by rosiglitazone was unaffected by the presence of the peroxisome proliferator activated receptor gamma antagonist GW9662. No effect of either rosiglitazone or metformin was observed on proinsulin promoter activity. Metformin stimulated IPF1 nuclear accumulation and DNA binding activity in a time-dependent manner, with maximal effects observed after 2 h.Conclusions/interpretation Metformin and rosiglitazone have direct effects on beta cell gene expression, suggesting that these agents may play a previously unrecognised role in the direct regulation of pancreatic beta cell function.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00125-006-0155-1

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Metformin increases insulin gene expression, possibly by nuclear accumulation of pdx1 and improved DNA-binding activity.

    “With respect to its effects on β-cell function, metformin was shown to increase insulin gene expression,346 possibly by nuclear accumulation of pdx1 and its subsequently improved DNA-binding activity.347”

    From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [347]

    Citation 346 is attached to the claim that metformin increases insulin gene expression; the proposed PDX1 mechanism has a separate citation. In the Results section, the cited paper instead reports no effect of metformin on proinsulin gene promoter activity in Min6 beta cells over 24 hours. The paper does report short-term IPF1 nuclear accumulation and increased DNA-binding activity, but that does not establish the expression claim attributed to citation 346 (page unavailable). (LLM, conf=0.88)

    Checked by a reasoning model — may be wrong.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Richardson, H., Campbell, S. C., Smith, S. A., & Macfarlane, W. M.
Affiliations
  • Newcastle University (GB)
  • GlaxoSmithKline (United Kingdom) (GB)
Corresponding author
Macfarlane, W. M.
Venue
Diabetologia
Published
2006-02-18
Volume
49
Issue
4
Pages
685-696
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W2020461632
Cited by
34
References
42
Citations by year
2026: 1 · 2025: 1 · 2023: 2 · 2018: 1 · 2016: 3 · 2015: 1 · 2013: 3 · 2012: 1
FWCI
5.05
Type
journal article
Language
en
Open access
Locations
  • Diabetologia (publishedVersion)
  • PubMed (publishedVersion)
  • University of Brighton Repository (University of Brighton) (submittedVersion)
  • Newcastle University ePrints (Newcastle Univesity)
Funders
  • GlaxoSmithKline
  • Diabetes UK
  • Directorate for Biological Sciences
Topics
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
Keywords
rosiglitazone, metformin, pancreatic beta cells, beta-cell gene expression, insulin promoter factor 1, FOXA2, type 2 diabetes, antidiabetic drugs, PPARγ, MIN6 cells, pancreatic islets, insulin secretion
MeSH terms
Rosiglitazone, Anilides, Animals, Cell Line, Cell Nucleus, DNA, Glucose, Metformin, Proinsulin, Promoter Regions, Genetic, Protein Binding, Time Factors, Trans-Activators, Gene Expression, Homeodomain Proteins, Active Transport, Cell Nucleus, Thiazolidinediones, Insulin-Secreting Cells, Mice, Rats, Hepatocyte Nuclear Factor 3-beta

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review